Soleno Therapeutics (SLNO)
(Delayed Data from NSDQ)
$46.88 USD
-1.26 (-2.62%)
Updated Sep 24, 2024 04:00 PM ET
After-Market: $46.86 -0.02 (-0.04%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth C Momentum D VGM
Brokerage Reports
0 items in cart
Soleno Therapeutics, Inc. [SLNO]
Reports for Purchase
Showing records 1 - 20 ( 34 total )
Company: Soleno Therapeutics, Inc.
Industry: Medical - Drugs
Optimized Entry and Exit Levels for SLNO 112223
Provider: Stock Traders Daily
Analyst: Research Department
Company: Soleno Therapeutics, Inc.
Industry: Medical - Drugs
Company: Soleno Therapeutics, Inc.
Industry: Medical - Drugs
Company: Soleno Therapeutics, Inc.
Industry: Medical - Drugs
Healthcare - Yas'' Weekly Recap of Our Key Notes and 9 Doc Calls Upcoming in 1Q20
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Soleno Therapeutics, Inc.
Industry: Medical - Drugs
Healthcare: Takeaways from our PWS Doc Call with Dr. Theresa Strong - Must Read
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Soleno Therapeutics, Inc.
Industry: Medical - Drugs
Healthcare - Join our PWS Call with Dr. Strong on Today at 12pm ET
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Soleno Therapeutics, Inc.
Industry: Medical - Drugs
2020 Is the Year of PWS: Bolster Your Know-How With Dr. Strong on Jan. 21
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Soleno Therapeutics, Inc.
Industry: Medical - Drugs
Healthcare -Join Our 1Q20 Doc Call Series in PWS, NASH, Omega-3s and Contraception
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Soleno Therapeutics, Inc.
Industry: Medical - Drugs
Company: Soleno Therapeutics, Inc.
Industry: Medical - Drugs
2Q19: Enrollment into PWS Trial Not Easy For Anyone - Read Our Analysis
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Soleno Therapeutics, Inc.
Industry: Medical - Drugs
Company: Soleno Therapeutics, Inc.
Industry: Medical - Drugs
Company: Soleno Therapeutics, Inc.
Industry: Medical - Drugs
Join Our Call with Dr. Strong on July 31 to Predict DESTINY PWS Readout
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Soleno Therapeutics, Inc.
Industry: Medical - Drugs
Healthcare -Recap of Our 27 Most Valuable Industry Notes in 2019
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Soleno Therapeutics, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Soleno Therapeutics, Inc.
Industry: Medical - Drugs
Company: Soleno Therapeutics, Inc.
Industry: Medical - Drugs
Healthcare - From NYC to Vienna - EASL Abstracts Galore: Attend our NASH Conference Mar. 28
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Soleno Therapeutics, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Soleno Therapeutics, Inc.
Industry: Medical - Drugs
Company: Soleno Therapeutics, Inc.
Industry: Medical - Drugs
Reasons Why You Can''t Miss Our 2nd Battle of NASH Thrones Conference on Mar. 28
Provider: Roth Capital Partners, Inc.